IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30

Incannex Healthcare Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026

$2.76−0.06 (-2.13%)

Close on Oct 19, 2026

Community

Notes and questions about Incannex Healthcare from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Incannex Healthcare's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Feb 27, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IXHL.

Revenue growth-100.0% · median -67.1%

Advertisement
300 × 250